Honeywell International Inc
$88.27B- Market cap
- $65.82B
- Debt
- +$34.94B
- Cash
- −$12.49B
Capital structure 65% equity / 35% debt · EV / Revenue 2.36x · EV proxy / EBITDA proxy 9.28x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: HON stock price vs DHR: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at DHR's multiple
Needs DHR P/E.
Implied fair value · at HON's multiple
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
13 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Capital structure 65% equity / 35% debt · EV / Revenue 2.36x · EV proxy / EBITDA proxy 9.28x
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Honeywell International Inc · implied price per share
Bear
$67.83
Base
$87.37
Bull
$114.31
DANAHER CORPORATION · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
3M Company
HON vs MMM
Parker-Hannifin Corp
HON vs PH
Eaton Corp plc
HON vs ETN
EMERSON ELECTRIC CO
HON vs EMR
AGILENT TECHNOLOGIES, INC.
HON vs A
ILLUMINA, INC.
HON vs ILMN
JOHNSON & JOHNSON
HON vs JNJ
ABBOTT LABORATORIES
HON vs ABT
LOEWS CORP
HON vs L
BERKSHIRE HATHAWAY INC
HON vs BRK-B
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe the market will re-rate Honeywell toward Danaher's P/E multiple (41.4x) then consider buying because DHR-implied price ($360.42) implies ~58.4% upside and HON posts strong ROIC (22.2%) and positive revenue growth (5.0%); otherwise remain neutral or wait for deleveraging given HON's higher leverage (Debt/Equity 1.7x, Net Debt/EBITDA 2.3x).
Honeywell (HON) trades at $227.53 while a Danaher-based P/E re‑rate implies $360.42 (58.4% upside). The valuation gap reflects HON's lower P/E (26.1x) versus Danaher (41.4x) and cheaper P/S and EV/Revenue multiples, but the market is already pricing some differences in business mix and leverage.
Supporting Metrics